Axcelis (ACLS) Stock Forecast, Price Target & Predictions
ACLS Stock Forecast
Axcelis stock forecast is as follows: an average price target of $137.00 (represents a 95.02% upside from ACLS’s last price of $70.25) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
ACLS Price Target
The average price target for Axcelis (ACLS) is $137.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $174.00 to $100.00. This represents a potential 95.02% upside from ACLS's last price of $70.25.
ACLS Analyst Ratings
According to 7 Wall Street analysts, Axcelis's rating consensus is 'Buy'. The analyst rating breakdown for ACLS stock is 0 'Strong Buy' (0.00%), 6 'Buy' (85.71%), 1 'Hold' (14.29%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Axcelis Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 12, 2024 | Christian Schwab | Craig-Hallum | $174.00 | $144.57 | 20.36% | 147.69% |
| May 03, 2024 | Christian Schwab | Craig-Hallum | $130.00 | $106.64 | 21.91% | 85.05% |
| Jan 05, 2023 | Quinn Bolton | Needham | $100.00 | $81.75 | 22.32% | 42.35% |
The latest Axcelis stock forecast, released on Jul 12, 2024 by Christian Schwab from Craig-Hallum, set a price target of $174.00, which represents a 20.36% increase from the stock price at the time of the forecast ($144.57), and a 147.69% increase from ACLS last price ($70.25).
Axcelis Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $152.00 |
| Last Closing Price | $70.25 | $70.25 | $70.25 |
| Upside/Downside | -100.00% | -100.00% | 116.37% |
In the current month, the average price target of Axcelis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Axcelis's last price of $70.25. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 02, 2024 | B. Riley | Buy | Buy | Hold |
| Jul 15, 2024 | Benchmark | Buy | Buy | Hold |
| Jul 12, 2024 | B. Riley | Buy | Buy | Hold |
| Jul 12, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Jun 20, 2024 | B. Riley Securities | Underperform | Underperform | Hold |
| Jun 20, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Jun 20, 2024 | B. Riley | Buy | Buy | Hold |
| May 03, 2024 | B. Riley Securities | Underperform | Underperform | Hold |
| May 03, 2024 | Craig-Hallum | Buy | Buy | Hold |
| May 03, 2024 | Craig-Hallum | - | Buy | Upgrade |
Axcelis's last stock rating was published by B. Riley on Aug 02, 2024. The company gave ACLS a "Buy" rating, the same as its previous rate.
Axcelis Financial Forecast
Axcelis Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $310.29M | $292.33M | $273.97M | $254.02M | $266.05M | $229.18M | $221.18M | $203.59M | $205.68M | $176.69M | $147.27M | $132.78M | $122.20M | $110.41M | $122.97M | $118.99M | $107.72M | $69.45M |
| Avg Forecast | $271.50M | $269.70M | $265.40M | $261.80M | $261.28M | $245.09M | $234.38M | $228.49M | $244.95M | $255.00M | $250.06M | $242.61M | $297.92M | $280.24M | $256.55M | $239.80M | $248.64M | $224.39M | $211.47M | $193.11M | $190.05M | $170.08M | $137.27M | $126.43M | $118.40M | $109.96M | $116.18M | $116.25M | $96.44M | $70.90M |
| High Forecast | $277.62M | $275.78M | $271.38M | $267.70M | $267.17M | $250.62M | $239.67M | $232.64M | $245.05M | $255.00M | $250.06M | $242.61M | $298.02M | $282.57M | $262.34M | $245.21M | $254.25M | $224.39M | $211.47M | $193.11M | $190.05M | $170.08M | $137.27M | $126.43M | $118.40M | $109.96M | $116.18M | $116.25M | $96.44M | $70.90M |
| Low Forecast | $267.03M | $265.26M | $261.03M | $257.49M | $256.98M | $241.06M | $230.52M | $224.34M | $244.85M | $255.00M | $250.06M | $242.61M | $297.82M | $279.40M | $252.33M | $235.85M | $244.55M | $224.39M | $211.47M | $193.11M | $190.05M | $170.08M | $137.27M | $126.43M | $118.40M | $109.96M | $116.18M | $116.25M | $96.44M | $70.90M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 8 | 7 | 6 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.04% | 1.07% | 1.06% | 1.07% | 1.02% | 1.05% | 1.05% | 1.08% | 1.04% | 1.07% | 1.05% | 1.03% | 1.00% | 1.06% | 1.02% | 1.12% | 0.98% |
Axcelis's average Quarter revenue forecast for Mar 24 based on 1 analysts is $242.61M, with a low forecast of $242.61M, and a high forecast of $242.61M. ACLS's average Quarter revenue forecast represents a -21.81% decrease compared to the company's last Quarter revenue of $310.29M (Dec 23).
Axcelis EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 8 | 7 | 6 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $79.05M | $75.00M | $63.71M | $54.26M | $67.27M | $46.34M | $49.45M | $47.40M | $49.35M | $38.14M | $26.71M | $21.88M | $18.36M | $17.41M | $19.34M | $15.93M | $16.26M | $3.67M |
| Avg Forecast | $51.16M | $50.82M | $50.01M | $49.33M | $49.23M | $46.18M | $44.16M | $43.05M | $46.16M | $48.05M | $47.12M | $54.19M | $56.14M | $52.81M | $48.34M | $42.84M | $40.72M | $39.01M | $36.77M | $33.86M | $33.04M | $29.57M | $23.87M | $12.03M | $20.59M | $19.12M | $20.20M | $10.83M | $16.77M | $12.33M |
| High Forecast | $52.31M | $51.97M | $51.14M | $50.44M | $50.34M | $47.22M | $45.16M | $43.84M | $46.18M | $48.05M | $47.12M | $65.03M | $56.16M | $53.25M | $49.43M | $51.40M | $48.86M | $39.01M | $36.77M | $40.64M | $33.04M | $29.57M | $23.87M | $14.44M | $20.59M | $19.12M | $20.20M | $13.00M | $16.77M | $12.33M |
| Low Forecast | $50.32M | $49.98M | $49.19M | $48.52M | $48.42M | $45.42M | $43.44M | $42.27M | $46.14M | $48.05M | $47.12M | $43.35M | $56.12M | $52.65M | $47.55M | $34.27M | $32.57M | $39.01M | $36.77M | $27.09M | $33.04M | $29.57M | $23.87M | $9.63M | $20.59M | $19.12M | $20.20M | $8.66M | $16.77M | $12.33M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.41% | 1.42% | 1.32% | 1.27% | 1.65% | 1.19% | 1.34% | 1.40% | 1.49% | 1.29% | 1.12% | 1.82% | 0.89% | 0.91% | 0.96% | 1.47% | 0.97% | 0.30% |
1 analysts predict ACLS's average Quarter EBITDA for Mar 24 to be $54.19M, with a high of $65.03M and a low of $43.35M. This is -31.45% lower than Axcelis's previous annual EBITDA (Dec 23) of $79.05M.
Axcelis Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 8 | 7 | 6 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $71.06M | $65.93M | $61.58M | $47.70M | $56.99M | $40.28M | $44.19M | $41.61M | $35.75M | $27.52M | $18.91M | $16.48M | $14.67M | $10.79M | $13.30M | $11.22M | $9.71M | $704.00K |
| Avg Forecast | $58.16M | $56.20M | $53.91M | $50.32M | $48.55M | $41.25M | $36.60M | $34.39M | $40.84M | $46.74M | $44.63M | $44.88M | $65.96M | $58.03M | $47.84M | $35.48M | $29.49M | $36.95M | $32.57M | $28.04M | $27.53M | $23.33M | $14.62M | $9.06M | $10.54M | $7.87M | $9.44M | $7.63M | $5.31M | $-196.63K |
| High Forecast | $59.87M | $57.85M | $55.49M | $51.79M | $49.97M | $42.46M | $37.67M | $35.39M | $42.04M | $48.56M | $45.02M | $53.85M | $66.62M | $58.70M | $49.24M | $42.57M | $35.39M | $36.95M | $32.57M | $33.65M | $27.53M | $23.33M | $14.62M | $10.88M | $10.54M | $7.87M | $9.44M | $9.16M | $5.31M | $-196.63K |
| Low Forecast | $56.92M | $55.00M | $52.76M | $49.24M | $47.51M | $40.37M | $35.81M | $33.39M | $39.97M | $44.92M | $44.25M | $35.90M | $64.29M | $57.70M | $46.81M | $28.38M | $23.59M | $36.95M | $32.57M | $22.44M | $27.53M | $23.33M | $14.62M | $7.25M | $10.54M | $7.87M | $9.44M | $6.10M | $5.31M | $-196.63K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.14% | 1.29% | 1.34% | 1.93% | 1.09% | 1.36% | 1.48% | 1.30% | 1.18% | 1.29% | 1.82% | 1.39% | 1.37% | 1.41% | 1.47% | 1.83% | -3.58% |
Axcelis's average Quarter net income forecast for Mar 24 is $44.88M, with a range of $35.90M to $53.85M. ACLS's average Quarter net income forecast represents a -36.84% decrease compared to the company's last Quarter net income of $71.06M (Dec 23).
Axcelis SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 8 | 7 | 6 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $33.93M | $33.91M | $31.86M | $28.89M | $31.34M | $29.56M | $26.30M | $23.87M | $26.48M | $23.41M | $23.39M | $20.40M | $22.58M | $19.41M | $19.48M | $17.24M | $17.51M | $15.76M |
| Avg Forecast | $39.87M | $39.61M | $38.97M | $38.45M | $38.37M | $35.99M | $34.42M | $33.55M | $35.97M | $37.45M | $36.72M | $25.74M | $43.75M | $41.15M | $37.67M | $20.35M | $21.85M | $32.95M | $31.05M | $16.09M | $27.91M | $24.98M | $20.16M | $11.22M | $17.39M | $16.15M | $17.06M | $11.72M | $14.16M | $10.41M |
| High Forecast | $40.77M | $40.50M | $39.85M | $39.31M | $39.23M | $36.80M | $35.20M | $34.16M | $35.99M | $37.45M | $36.72M | $30.89M | $43.76M | $41.50M | $38.52M | $24.42M | $26.22M | $32.95M | $31.05M | $19.30M | $27.91M | $24.98M | $20.16M | $13.46M | $17.39M | $16.15M | $17.06M | $14.07M | $14.16M | $10.41M |
| Low Forecast | $39.21M | $38.95M | $38.33M | $37.81M | $37.74M | $35.40M | $33.85M | $32.94M | $35.96M | $37.45M | $36.72M | $20.59M | $43.74M | $41.03M | $37.06M | $16.28M | $17.48M | $32.95M | $31.05M | $12.87M | $27.91M | $24.98M | $20.16M | $8.98M | $17.39M | $16.15M | $17.06M | $9.38M | $14.16M | $10.41M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.78% | 0.82% | 0.85% | 1.42% | 1.43% | 0.90% | 0.85% | 1.48% | 0.95% | 0.94% | 1.16% | 1.82% | 1.30% | 1.20% | 1.14% | 1.47% | 1.24% | 1.51% |
Axcelis's average Quarter SG&A projection for Mar 24 is $25.74M, based on 1 Wall Street analysts, with a range of $20.59M to $30.89M. The forecast indicates a -24.14% fall compared to ACLS last annual SG&A of $33.93M (Dec 23).
Axcelis EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 4 | 2 | 1 | 1 | 2 | 7 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 8 | 7 | 6 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $2.17 | $2.01 | $1.88 | $1.46 | $1.74 | $1.22 | $1.34 | $1.25 | $1.07 | $0.82 | $0.56 | $0.49 | $0.44 | $0.32 | $0.40 | $0.34 | $0.30 | $0.02 |
| Avg Forecast | $1.78 | $1.72 | $1.65 | $1.54 | $1.49 | $1.26 | $1.12 | $1.05 | $1.25 | $1.43 | $1.37 | $1.24 | $2.02 | $1.78 | $1.46 | $1.30 | $1.42 | $1.13 | $0.99 | $0.92 | $0.84 | $0.71 | $0.45 | $0.36 | $0.32 | $0.24 | $0.29 | $0.26 | $0.16 | $-0.01 |
| High Forecast | $1.83 | $1.77 | $1.70 | $1.59 | $1.53 | $1.30 | $1.15 | $1.08 | $1.29 | $1.49 | $1.38 | $1.24 | $2.04 | $1.80 | $1.51 | $1.37 | $1.46 | $1.13 | $0.99 | $0.92 | $0.84 | $0.71 | $0.45 | $0.36 | $0.32 | $0.24 | $0.29 | $0.26 | $0.16 | $-0.01 |
| Low Forecast | $1.74 | $1.68 | $1.61 | $1.51 | $1.45 | $1.24 | $1.10 | $1.02 | $1.22 | $1.37 | $1.35 | $1.24 | $1.97 | $1.77 | $1.43 | $1.24 | $1.39 | $1.13 | $0.99 | $0.92 | $0.84 | $0.71 | $0.45 | $0.36 | $0.32 | $0.24 | $0.29 | $0.26 | $0.16 | $-0.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.13% | 1.28% | 1.12% | 1.23% | 1.08% | 1.35% | 1.36% | 1.27% | 1.15% | 1.26% | 1.37% | 1.37% | 1.33% | 1.39% | 1.32% | 1.85% | -3.33% |
According to 1 Wall Street analysts, Axcelis's projected average Quarter EPS for Mar 24 is $1.24, with a low estimate of $1.24 and a high estimate of $1.24. This represents a -42.74% decrease compared to ACLS previous annual EPS of $2.17 (Dec 23).
Axcelis Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| LRCX | Lam Research | $70.17 | $649.74 | 825.95% | Buy |
| ACLS | Axcelis | $70.25 | $137.00 | 95.02% | Buy |
| INDI | indie Semiconductor | $4.69 | $9.00 | 91.90% | Buy |
| UCTT | Ultra Clean | $35.45 | $57.00 | 60.79% | Buy |
| ONTO | Onto Innovation | $162.84 | $258.33 | 58.64% | Buy |
| TER | Teradyne | $102.80 | $153.18 | 49.01% | Buy |
| ASML | ASML | $662.16 | $976.20 | 47.43% | Buy |
| KLIC | Kulicke and Soffa Industries | $45.58 | $65.00 | 42.61% | Hold |
| COHU | Cohu | $25.36 | $30.00 | 18.30% | Buy |
| AMAT | Applied Materials | $169.31 | $199.28 | 17.70% | Buy |
| PLAB | Photronics | $23.94 | $25.50 | 6.52% | Buy |
| KLAC | KLA | $615.66 | $619.00 | 0.54% | Buy |